Showing results (681-690 of 776) with videos related to
Sort By:
Pageof 78
Head & Neck|October 13, 2020
Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening programWilliam Wang-Yu Su, Yi-Huah Lee, Amy Ming-Fang Yen, et al.Cancer|May 22, 2015
Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening ProgramHan-Mo Chiu, Sam Li-Sheng Chen, Amy Ming-Fang Yen, et al.Journal of Clinical Gastroenterology|November 3, 2017
Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based ColonoscopyHsiao-Hsuan Jen, Chen-Yang Hsu, Sam Li-Sheng Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|March 25, 2018
Rlip depletion prevents spontaneous neoplasia in TP53 null miceSanjay Awasthi, Joshua Tompkins, Jyotsana Singhal, et al.Nature Cell Biology|December 6, 2016
A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasisAbdol-Hossein Rezaeian, Chien-Feng Li, Ching-Yuan Wu, et al.Cancers|July 16, 2020
Precision Science on Incidence and Progression of Early-Detected Small Breast Invasive Cancers by Mammographic FeaturesRene Wei-Jung Chang, Shu-Lin Chuang, Chen-Yang Hsu, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2018
Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical TestsYi-Chia Lee, Jean Ching-Yuan Fann, Tsung-Hsien Chiang, et al.International Journal of Cancer|February 1, 2014
A new insight into fecal hemoglobin concentration-dependent predictor for colorectal neoplasiaAmy Ming-Fang Yen, Sam Li-Sheng Chen, Sherry Yueh-Hsia Chiu, et al.International Journal of Epidemiology|September 6, 2018
Effects of screening and universal healthcare on long-term colorectal cancer mortalityYi-Chia Lee, Chen-Yang Hsu, Sam Li-Sheng Chen, et al.Iscience|August 9, 2023
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitorsLinlin Guo, Atish Mohanty, Sharad Singhal, et al.Pageof 78